SLS (SELLAS Life Sciences Group) 3-Year Book Growth Rate: 26.10% (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SLS SELLAS Life Sciences Group Inc SLS
25 GF Score
Price $12.20
View Full Analysis

What is SELLAS Life Sciences Group 3-Year Book Growth Rate?

SELLAS Life Sciences Group SLS +3.48% 25 3-Year Book Growth Rate is 26.10% as of Jun. 2026. GuruFocus rates SLS with a GF Score™ of 25/100. Among 1,131 Biotechnology companies, SELLAS Life Sciences Group ranks better than 87.53% on this metric.

SELLAS Life Sciences Group's Book Value per Share for the quarter that ended in Jun. 2026 was $0.68.

During the past 12 months, SELLAS Life Sciences Group's average Book Value per Share Growth Rate was 168.20% per year. During the past 3 years, the average Book Value per Share Growth Rate was 26.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Book Value per Share growth rate.

During the past 13 years, the highest 3-Year average Book Value per Share Growth Rate of SELLAS Life Sciences Group was 132.00% per year. The lowest was -87.50% per year. And the median was -42.20% per year.

SELLAS Life Sciences Group  (NAS:SLS) 3-Year Book Growth Rate Explanation

Book Value per Share is the ratio of equity available to common shareholders divided by the shares outstanding. Book value per share effectively indicates a firm's net asset value on a per-share basis. It can be used by investors to gauge whether a stock price is undervalued by comparing it to the firm's market value per share. Theoretically, it is what the shareholders will receive if the company is liquidated.

SELLAS Life Sciences Group 3-Year Book Growth Rate Related Terms

SLS vs IOVA, COAG, NUVB: 3-Year Book Growth Rate Comparison

For the Biotechnology subindustry, SELLAS Life Sciences Group's 3-Year Book Growth Rate, along with its competitors' market caps and 3-Year Book Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

SELLAS Life Sciences Group 3-Year Book Growth Rate vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, SELLAS Life Sciences Group's 3-Year Book Growth Rate distribution charts can be found below:

* The bar in red indicates where SELLAS Life Sciences Group's 3-Year Book Growth Rate falls into.


SLS
25GF Score
SELLAS Life Sciences Group Inc SLS
3-Year Book Growth Rate is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

SELLAS Life Sciences Group 3-Year Book Growth Rate Calculation

This is the 3-year average growth rate of Book Value per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Book Value per Share growth rate.

What does a 3-Year Book Growth Rate of 26.10% mean?
SELLAS Life Sciences Group (SLS) has a 3-Year Book Growth Rate of 26.10% as of Jun. 2026. 3-Year Book Growth Rate is the 3-year average growth rate of Book Value per Share. View historical data for SELLAS Life Sciences Group and its competitors. According to the industry distribution chart, SELLAS Life Sciences Group ranks #141 out of 1131 companies in the Biotechnology industry, placing it in the top 12.5%.
Is SELLAS Life Sciences Group's 3-Year Book Growth Rate too high?
SELLAS Life Sciences Group's current 3-Year Book Growth Rate is 26.10%. Based on the distribution chart, SELLAS Life Sciences Group ranks #141 out of 1131 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers. Overall, SELLAS Life Sciences Group has a GF Score™ of 25/100, reflecting its overall financial health beyond just this single metric.
How does SELLAS Life Sciences Group's 3-Year Book Growth Rate compare to IOVA and COAG?
According to the Biotechnology industry distribution chart, SELLAS Life Sciences Group ranks #141 out of 1131 companies for 3-Year Book Growth Rate. This places SELLAS Life Sciences Group in the top 13% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year Book Growth Rate for a Biotechnology company?
A good 3-Year Book Growth Rate depends on the Biotechnology industry context. However, 3-Year Book Growth Rate should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year Book Growth Rate mean?
A high 3-Year Book Growth Rate can signal that a stock is expensive relative to its fundamentals. 3-Year Book Growth Rate is the 3-year average growth rate of Book Value per Share. View historical data for SELLAS Life Sciences Group and its competitors. SELLAS Life Sciences Group's current 3-Year Book Growth Rate is 26.10%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is SELLAS Life Sciences Group stock overvalued right now?
SELLAS Life Sciences Group (SLS) has a current 3-Year Book Growth Rate of 26.10%. The current 3-Year Book Growth Rate is 26.10%. SELLAS Life Sciences Group's overall GF Score™ is 25/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year Book Growth Rate calculated?
3-Year Book Growth Rate is calculated from a company's financial statements. For SELLAS Life Sciences Group (SLS), the current 3-Year Book Growth Rate is 26.10% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

SELLAS Life Sciences Group Business Description

Other Exchanges RXK3:Germany
Address 7 Times Square, Suite 2503, New York, NY, USA, 10036
SELLAS Life Sciences Group Inc is a late-stage clinical biopharmaceutical company focused on the development of novel therapeutics for a broad range of cancer indications. The company's product candidates currently include galinpepimut-S, or GPS, a peptide immunotherapy directed against the Wilms tumor 1, or WT1, antigen, and GFH009, a selective small molecule cyclin-dependent kinase 9, or CDK9, inhibitor.
25GF Score

Get the complete analysis for SLS

3-Year Book Growth Rate is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$12.20
Price